Europe Medical Cannabis Snapshot Report 2024: Germnay, UK, Poland, Czech Republic, Switzerland Market Sizes, Top Brands, Product Forms, Consumption Patterns, Product Origin, and Regulatory Landscapes
December 03, 2024 04:27 ET
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Europe Medical Cannabis Snapshot Bundle" report has been added to ResearchAndMarkets.com's offering. The Europe Medical Cannabis Snapshot Bundle...
Global and US CBD Regulatory Database 2024: Essential Information About How CBD is Regulated in Key Markets to Ensure your Business Complies with All Legal Requirements
November 27, 2024 04:13 ET
|
Research and Markets
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Global CBD Regulatory Database" database has been added to ResearchAndMarkets.com's offering. This database bundle provide essential information...
Global and United States Medical and Recreational Cannabis Database 2024: Legal Status, Production and Licensing, Consumption and Prescription, Legal Proposals and Political Initiatives
November 27, 2024 04:12 ET
|
Research and Markets
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Global Medical and Recreational Cannabis Database" database has been added to ResearchAndMarkets.com's offering. This dataset provides essential...
Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
November 14, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray Medical announced the launch of its first commercial German grown medical cannabis flowers from its Aphria RX GmbH (“Aphria RX”) facility.
Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
November 07, 2024 07:00 ET
|
Tilray Brands, Inc.
This trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from negative chemotherapy-induced side effects.
International Directory of Medical Cannabis Companies 2024
October 04, 2024 04:54 ET
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "International Directory of Medical Cannabis Companies 2024" directory has been added to ResearchAndMarkets.com's offering.The International Directory...
Tilray Medical Launches Redecan Cannabis Brand in Australia
September 18, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray's EU-GMP Certified Redecan Cannabis Now Available in Australia with Medical Prescription.
Organic Remedies Raises $15,000 for Speranza Animal Rescue
September 17, 2024 08:15 ET
|
Organic Remedies
Organic Remedies proudly announced it has raised $15,000 for Speranza Animal Rescue during its month-long Dog Days of Summer campaign in August.
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
September 09, 2024 07:00 ET
|
Tilray Brands, Inc.
LISBON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the...
World Cannabis Market Report 2024: Examining Five Drivers Shaping Legal Cannabis
September 06, 2024 05:22 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "World Market for Cannabis" report has been added to ResearchAndMarkets.com's offering. Backed partly by existing legacy use, there is a broad-based...